MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
SEER stock logo

SEER

Seer, Inc.

$1.69
-0.1
 (-5.59%)
Exchange:  NASDAQ
Market Cap:  92.919M
Shares Outstanding:  60.911M
Delayed data
Calculate SEER Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Biotechnology
   
CEO:  Omid C. Farokhzad
Full Time Employees:  134
Address: 
3800 Bridge Parkway
Redwood City
CA
94065
US
Website:  https://seer.bio
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue15,18213,94716,119
Gross Profit1,4496,8321,902
EBITDA-80,699-93,925-72,347
Operating Income-104,942-100,101-78,451
Net Income-86,277-86,599-73,600

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets436,269366,597296,083
Total Liabilities39,36539,02836,776
Total Stockholders Equity396,904327,569259,307
Total Debt28,25925,96423,652
Cash and Cash Equivalents32,49940,75347,285

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-59,065-46,109-44,448
Capital Expenditure-7,309-3,584-1,797
Free Cash Flow-66,374-49,693-46,245
Net Income-86,277-86,599-73,600
Net Change in Cash-20,7098,2546,532

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)48,875.731Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)49,724.268Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)49,300Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-49,724.268Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-48,875.731Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-49,300Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)-4,066.319Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)-3,976.341Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)-4,021.330Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)202,979.356Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)206,503.303Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)204,741.331Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)-0.070Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)-0.070Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)-0.070Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
6.54
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
-1.42
?Enterprise Value
 (TTM)
: 
74.127M  ?EV/FCF
 (TTM)
: 
-1.49
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.27  ?ROIC
 (TTM)
: 
-0.28
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.1
?P/B
 (TTM)
: 
0.42  ?Current Ratio
 (TTM)
: 
17.73

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about SEER valuation

Is Seer, Inc. (SEER) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Seer, Inc. (SEER) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is SEER a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether SEER trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is SEER’s P/E ratio?

You can see SEER’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for SEER?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is SEER a good long-term investment?

Whether SEER fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

SEER

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-5.59
MARKETSnap

Trading Metrics:

Open: 1.79   Previous Close: 1.79
Day Low: 1.69   Day High: 1.79
Year Low: 1.65   Year High: 2.41
Price Avg 50: 1.84   Price Avg 200: 1.95
Volume: 436657   Average Volume: 350914

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for SEER

Relevant news

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
03-06-2026 18:00
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders
27-05-2026 16:30
The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
26-05-2026 16:05
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
21-05-2026 16:38
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
Seer Q1 Earnings Call Highlights
14-05-2026 00:14
Seer Q1 Earnings Call Highlights

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read